| Intravenous streptokinase and percutaneous transluminal coronary angioplasty in acute myocardial infarction. | |
| | |
MedLine Citation:
|
PMID: 2963686 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Intravenous streptokinase already has been demonstrated safe and beneficial in acute myocardial infarction. The adjunction of early angiography seems to be safe, providing the possibility of full revascularization in a larger number of patients with a high rate of primary success. The improvement of global ventricular function, the reduction of mortality, post infarction angina and reocclusion have to be confirmed by longer follow-up. |
| | |
Authors:
|
R Bonan |
Related Documents
:
|
6608636 - Early bypass grafting following intracoronary thrombolysis with streptokinase. 7883296 - Serum magnesium: a prognostic tool of acute myocardial infarction. 12204726 - Intrapericardial fibrinolytic therapy in purulent pericarditis. 4075606 - Intravenous versus intracoronary streptokinase in acute myocardial infarction. 9386086 - Papillary muscle discoordination rather than increased annular area facilitates mitral ... 7943376 - Myocardial function and metabolism in pig hearts after relief from chronic partial coro... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: The Canadian journal of cardiology Volume: 3 Suppl A ISSN: 0828-282X ISO Abbreviation: Can J Cardiol Publication Date: 1987 Nov |
Date Detail:
|
Created Date: 1988-04-07 Completed Date: 1988-04-07 Revised Date: 2008-04-09 |
Medline Journal Info:
|
Nlm Unique ID: 8510280 Medline TA: Can J Cardiol Country: CANADA |
Other Details:
|
Languages: eng Pagination: 30A-33A Citation Subset: IM |
Affiliation:
|
Cardiac Catherterization Laboratory, Montreal Heart Institute, Quebec. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Balloon* Clinical Trials as Topic Humans Infusions, Intravenous Myocardial Infarction / drug therapy, mortality, therapy* Random Allocation Streptokinase / therapeutic use* Time Factors |
| Chemical | |
Reg. No./Substance:
|
EC 3.4.-/Streptokinase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: On a factor present in tumor cells, capable of decreasing thermotolerance in mice
Next Document: B-cell lineage acute lymphoblastic leukemia with i(7q) and t(9;9)(p22;p24).